Search - tctmd.com

Displaying 321 - 340 of 520

Sort: Relevancy | Date

Presentation TCT 2013

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke

Presenter: Saibal Kar

October 29, 2013

Presentation TCT 2013

Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives

Presenter: Eugenia Nikolsky

October 28, 2013

Presentation TCT 2013

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Presenter: George Dangas

October 28, 2013

News Conference News TCT 2013

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

October 28, 2013

News Conference News TCT 2013

Experts Discuss Efficacy, Safety of Watchman Device

October 28, 2013

Presentation TCT 2013

Stroke, Bleeding and Risk Scores in Atrial Fibrillation (with and without Anticoagulation)

Presenter: Stefan Bertog

October 27, 2013

Presentation TCT 2013

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Presenter: Michael Ezekowitz

October 27, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

October 04, 2013

News Daily News

No Administrar Aspirina Pre-PCI es Causa Habitual de Complicaciones

Caitlin E. Cox

October 04, 2013

News Daily News

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Caitlin E. Cox

October 04, 2013

News Daily News

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

September 30, 2013

News Daily News

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Yael L. Maxwell

September 27, 2013

Presentation VEINS 2013

Difficult Anticoagulation Decisions: Case 1

Presenter: Teresa L. Carman

September 22, 2013

Presentation VEINS 2013

Proper Duration of Anticoagulation: Can This Be Patient Specific?

Presenter: Michael R. Jaff

September 21, 2013

Presentation VEINS 2013

Difficult Anticoagulation Decisions

Presenter: John R. Bartholomew

September 21, 2013

Presentation VEINS 2013

Antiplatelets, Anticoagulation Post Intervention and Surveillance

Presenter: John R. Bartholomew

September 20, 2013

News Daily News

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

September 20, 2013

News Daily News

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

L.A. McKeown

September 20, 2013

News Daily News

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

L.A. McKeown

September 20, 2013

Advertisement

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke

Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

Experts Discuss Efficacy, Safety of Watchman Device

Stroke, Bleeding and Risk Scores in Atrial Fibrillation (with and without Anticoagulation)

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

No Administrar Aspirina Pre-PCI es Causa Habitual de Complicaciones

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Difficult Anticoagulation Decisions: Case 1

Proper Duration of Anticoagulation: Can This Be Patient Specific?

Difficult Anticoagulation Decisions

Antiplatelets, Anticoagulation Post Intervention and Surveillance

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content